FORMULATION AND EVALUATION OF DEXLANSOPRAZOLE DELAYED RELEASE CAPSULES

Journal Title: Indian Journal of Research in Pharmacy and Biotechnology - Year 2013, Vol 1, Issue 1

Abstract

The present research work is formulation and evaluation of dexlansoprazole delayed release capsules. Dexlansoprazole is proton pump inhibitor (PPI) used in treatment of gastro esophageal reflux disease (G.E.R.D), Erosive esophagitis (E.E) and acid – related factors. In this research work various polymers like HPMC P55 S, Eudragit L 100 were used as enteric coating polymers were prepared in a fluidized bed coater (FBC). The pre-formulation studies such as solubility and compatability studies were carried out. In the formulation study of dexlansoprazole different formulation (F1 - F10) have been formulated and evaluated for acid resisitance, dissolution profile and release kinetics. The drug percentage release is more when compared with the marketed product. Stability study was done at various storage conditions and months for description, assay, water content, related substances. Mainly research work is to develop a pharmaceutically equivalent low cost quality improved and stable formulation and evaluation of dexlansoprazole delayed release capsules comparable to innovator product.

Authors and Affiliations

Peer Basha Syed, Chakravarthi V,Venkateswarlu B,Koteswararao P, Farooq Ahmed

Keywords

Related Articles

Studies of relative and specific viscosities of Aceclofenacin 70% Dioxane water mixture at different temperature

Acelofenac drug plays their own identity in the drug, pharmaceutical and medicinal sciences in last decades. Hence, the viscometric study were carried out at 70% various percentage of solvent. The result obtained durin...

A simple validated UV spectrophotometric method for quantitative analysis of Levetiracetam in pharmaceutical dosage form

In the present study simple, precise, accurate, economical and reliable UV spectrophotometric method has been developed for the estimation of Levetiracetam in tablet dosage form. The drug shows maximum absorption (maxi...

Protective effect of aqueous extract of Curcuma longa on ethanol induced Hepatotoxicity in Rat

In ethno medicinal practices, the traditional healers use the genus Curcuma for the treatment of various ailments Turmeric is a spice derived from the rhizomes of Curcuma longa, which is a member of the ginger family (...

RECENT TRENDS IN SCOPE AND OPPORTUNITY OF CLINICAL RESEARCH IN INDIA

Clinical Research is one of the most knowledge-intensive industry. It is complete biography of drug from its inception in the lab to its introduction to the consumer market and beyond. Any molecule is identified is sub...

ADR MONITORING IN HYPERTENSION OUT PATIENT DEPARTMENT OF HOSPITAL

Adverse drug reactions (ADRs) to anti-hypertensive agents are common and can lead to noncompliance or even discontinuation of therapy. There is paucity of such data in the Indian context. We deemed it worthwhile to ass...

Download PDF file
  • EP ID EP33018
  • DOI -
  • Views 411
  • Downloads 0

How To Cite

Peer Basha Syed, Chakravarthi V, Venkateswarlu B, Koteswararao P, Farooq Ahmed (2013). FORMULATION AND EVALUATION OF DEXLANSOPRAZOLE DELAYED RELEASE CAPSULES. Indian Journal of Research in Pharmacy and Biotechnology, 1(1), -. https://europub.co.uk/articles/-A-33018